NE

Neogenomics

NEO
NASDAQHealth Care

Income Statement

Total Revenue$660.57M
Gross Profit$290.1M
Operating Income$-92.11M
EBITDA$7.42M
EBIT$-74.06M
Pre-tax Income$-102.19M
Net Income$-78.73M

Balance Sheet

Cash Equivalent$354M
Total Debt$606.58M
Book Value$912.46M
Book Value Per Share7.13

Key Ratios

Return on Equity (ROE)-8.72%
Return on Assets (ROA)-4.81%
Return on Invested Capital (ROI)-5.45%
Net Profit Margin-11.92%
Current Ratio1.98
Quick Ratio1.82
Long-Term Debt / Equity0.38